| Paul G Flatley, DO | |
|
5656 E Orange Blossom Ln Ste 5, Phoenix, AZ 85018-8139 | |
| (602) 601-7429 | |
| (602) 601-7428 |
| Full Name | Paul G Flatley |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 29 Years |
| Location | 5656 E Orange Blossom Ln Ste 5, Phoenix, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295785145 | NPI | - | NPPES |
| 504386 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083A0300X | Preventive Medicine - Addiction Medicine | 3162 (Arizona) | Secondary |
| 146D00000X | Personal Emergency Response Attendant | 3162 (Arizona) | Primary |
| Entity Name | Scottsdale Emergency Associates Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083671432 PECOS PAC ID: 3274425970 Enrollment ID: O20040326001331 |
News Archive
An international multidisciplinary consortium, co-led by the European Organisation for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), has been convened to generate recommendations to standardize the use, analysis, and interpretation of patient-reported outcome (PRO) data in cancer clinical trials.
The number of U.S. senior medical students choosing categorical internal medicine residencies increased for the fourth consecutive year.
An observational study conducted by Medversant Technologies, LLC, (www.medversant.com), the nation's exclusive provider of AutoVerifi™ technology (U.S. Patent 7,529,682) that continuously monitors Web-based credentials verification solutions for hospitals, health plans, state Medicaid programs, and other healthcare settings, determined that of 29,845 healthcare practitioners with professed current medical licensure, 1.9 percent were practicing without a license and 18.7 percent were flagged with one or more "adverse findings" – including malpractice, expired license, and credentials falsification.
Awareness campaigns alone may not be sufficient to reduce the number of accidents on South African roads. Introducing compulsory third-party insurance and the imminent emergence of self-driving cars may have an impact.
By modifying the CRISPR-Cas genome editing system, Whitehead Institute researchers are now able to manipulate Candida albicans' genome systematically-an approach that could help identify novel targets for therapies against this serious pathogen for which there are a limited number of anti-fungal agents.
› Verified 9 days ago
| Entity Name | Pgf Medical Services Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356857262 PECOS PAC ID: 9032459557 Enrollment ID: O20190320001724 |
News Archive
An international multidisciplinary consortium, co-led by the European Organisation for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), has been convened to generate recommendations to standardize the use, analysis, and interpretation of patient-reported outcome (PRO) data in cancer clinical trials.
The number of U.S. senior medical students choosing categorical internal medicine residencies increased for the fourth consecutive year.
An observational study conducted by Medversant Technologies, LLC, (www.medversant.com), the nation's exclusive provider of AutoVerifi™ technology (U.S. Patent 7,529,682) that continuously monitors Web-based credentials verification solutions for hospitals, health plans, state Medicaid programs, and other healthcare settings, determined that of 29,845 healthcare practitioners with professed current medical licensure, 1.9 percent were practicing without a license and 18.7 percent were flagged with one or more "adverse findings" – including malpractice, expired license, and credentials falsification.
Awareness campaigns alone may not be sufficient to reduce the number of accidents on South African roads. Introducing compulsory third-party insurance and the imminent emergence of self-driving cars may have an impact.
By modifying the CRISPR-Cas genome editing system, Whitehead Institute researchers are now able to manipulate Candida albicans' genome systematically-an approach that could help identify novel targets for therapies against this serious pathogen for which there are a limited number of anti-fungal agents.
› Verified 9 days ago
| Entity Name | Tec Emergency Physicians Of Arizona, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245772870 PECOS PAC ID: 6204256084 Enrollment ID: O20201016000157 |
News Archive
An international multidisciplinary consortium, co-led by the European Organisation for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), has been convened to generate recommendations to standardize the use, analysis, and interpretation of patient-reported outcome (PRO) data in cancer clinical trials.
The number of U.S. senior medical students choosing categorical internal medicine residencies increased for the fourth consecutive year.
An observational study conducted by Medversant Technologies, LLC, (www.medversant.com), the nation's exclusive provider of AutoVerifi™ technology (U.S. Patent 7,529,682) that continuously monitors Web-based credentials verification solutions for hospitals, health plans, state Medicaid programs, and other healthcare settings, determined that of 29,845 healthcare practitioners with professed current medical licensure, 1.9 percent were practicing without a license and 18.7 percent were flagged with one or more "adverse findings" – including malpractice, expired license, and credentials falsification.
Awareness campaigns alone may not be sufficient to reduce the number of accidents on South African roads. Introducing compulsory third-party insurance and the imminent emergence of self-driving cars may have an impact.
By modifying the CRISPR-Cas genome editing system, Whitehead Institute researchers are now able to manipulate Candida albicans' genome systematically-an approach that could help identify novel targets for therapies against this serious pathogen for which there are a limited number of anti-fungal agents.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paul G Flatley, DO 5656 E Orange Blossom Ln Ste 5, Phoenix, AZ 85018-8139 Ph: (602) 601-7429 | Paul G Flatley, DO 5656 E Orange Blossom Ln Ste 5, Phoenix, AZ 85018-8139 Ph: (602) 601-7429 |
News Archive
An international multidisciplinary consortium, co-led by the European Organisation for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), has been convened to generate recommendations to standardize the use, analysis, and interpretation of patient-reported outcome (PRO) data in cancer clinical trials.
The number of U.S. senior medical students choosing categorical internal medicine residencies increased for the fourth consecutive year.
An observational study conducted by Medversant Technologies, LLC, (www.medversant.com), the nation's exclusive provider of AutoVerifi™ technology (U.S. Patent 7,529,682) that continuously monitors Web-based credentials verification solutions for hospitals, health plans, state Medicaid programs, and other healthcare settings, determined that of 29,845 healthcare practitioners with professed current medical licensure, 1.9 percent were practicing without a license and 18.7 percent were flagged with one or more "adverse findings" – including malpractice, expired license, and credentials falsification.
Awareness campaigns alone may not be sufficient to reduce the number of accidents on South African roads. Introducing compulsory third-party insurance and the imminent emergence of self-driving cars may have an impact.
By modifying the CRISPR-Cas genome editing system, Whitehead Institute researchers are now able to manipulate Candida albicans' genome systematically-an approach that could help identify novel targets for therapies against this serious pathogen for which there are a limited number of anti-fungal agents.
› Verified 9 days ago